Alan Wright, MD, MPH, is the chief medical officer at Roche Diagnostics Corp.

In this role he serves as Roche’s clinical spokesperson and provides guidance on a wide range of policy and clinical practice issues related to diagnostic medicine. Wright has extensive experience in the managed care, pharmaceutical and biotechnology industries.

Prior to joining Roche, Wright served as senior vice president of health improvement strategies for Miraca Life Sciences. He also worked as vice president for product strategy and business development for Resolution Health, a privately held analytics and intervention company serving the managed care market place.

Until 2005, Wright was chairman and CEO of Star Pharmaceuticals, a company that he founded in 2002 to serve the needs of the urological community. Previously, he held positions as senior vice president and chief science officer of Caremark and senior vice president and chief medical officer for AdvancePCS.

Wright graduated magna cum laude with a bachelor’s degree from Pennsylvania State University, received his medical doctorate from the University of Pennsylvania, and completed his residency in internal medicine at Temple University in Philadelphia. While at Temple, he served as chief medical resident from 1985 to 1986 and completed his MPH at Johns Hopkins.

Wright is a member of the American Medical Association, the American College of Physicians, and several journal editorial boards. He is also certified as a diplomat to the American Board of Internal Medicine and the National Board of Medical Examiners.